Comparing medicine and surgery for prolactinoma
Part of Brain & nervous system, Cancer, Hormones & metabolism clinical trials.
This trial compares medicine (bromocriptine) and surgery for people with a certain type of pituitary tumor (prolactinoma) that has not spread too far. It aims to see which approach works best and is safest for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prolactin level is more than 3 times the normal upper limit.
- Your MRI shows a pituitary adenoma that is Knosp Grade 0, 1, or 2.
- You are not taking antidepressants or other psychiatric medications.
- You are not allergic to bromocriptine and can tolerate surgery.
- If you are a woman, you have not had surgery that causes infertility and have not had no periods for more than 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study examines the inflammatory environment inside pituitary tumors (small glands in the brain) to better understand how they grow and respond to treatment. You would have surgery to remove the tumor as part of your normal care, and researchers would study the removed tissue to learn more.
This trial compares two medications, cabergoline and bromocriptine, to see which works better for women with high prolactin levels (hyperprolactinemia). It aims to find a more effective treatment to help manage this condition, which can affect fertility and menstrual cycles.
This trial tests a drug called pasireotide for people with prolactinoma (a type of pituitary tumor) who cannot use standard dopamine agonist medicines or whose tumors do not shrink enough with them. It may be an option if surgery isn't right for you.
This trial tests a higher dose of the drug cabergoline to see if it works better for small prolactin-secreting tumors (microprolactinomas) in premenopausal women who have not been treated before. It aims to find a safe and effective way to lower high prolactin levels and shrink the tumor.
This study looks at how changes in estrogen before diagnosis affect the growth of prolactin-secreting pituitary tumors (prolactinomas). The goal is to understand why some tumors are larger than others.
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
Hear when a new Pituitary Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.